Rutgers Cancer Institute of New Jersey at University Hospital is a clinical research site located in Newark, New Jersey, United States 07103.
Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.
Rutgers Cancer Institute of New Jersey at University Hospital has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Hepatocellular Carcinoma, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8.
Sponsors: Genentech, Inc., Rutgers, The State University of New Jersey.
Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rutgers Cancer Institute of New Jersey at University Hospital has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rutgers Cancer Institute of New Jersey at University Hospital has 2 clinical trials on record, with 1 currently active. Their work covers Hepatocellular Carcinoma, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8.
Rutgers Cancer Institute of New Jersey at University Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.